Patents by Inventor Bimal K. Banik

Bimal K. Banik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polycyclic ? lactam derivatives for the treatment of cancer
    Patent number: 8946409
    Abstract: Provided herein are polycyclic ?-lactam compounds, compositions thereof and methods for the treatment and prevention of diseases such as cancer, including pancreatic cancer and pancreatic cancers resistant to mainline chemotherapeutic agents.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: February 3, 2015
    Assignee: Board of Regents, The University of Texas System
    Inventors: Frederick F. Becker, Bimal K. Banik
  • POLYCYCLIC BETA LACTAM DERIVATIVES FOR THE TREATMENT OF CANCER
    Publication number: 20140066423
    Abstract: Provided herein are polycyclic ?-lactam compounds, compositions thereof and methods for the treatment and prevention of diseases such as cancer, including pancreatic cancer and pancreatic cancers resistant to mainline chemotherapeutic agents.
    Type: Application
    Filed: January 27, 2012
    Publication date: March 6, 2014
    Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Frederick F. Becker, Bimal K. Banik
  • Antitumor dibenzofluorene derivatives
    Patent number: 6479662
    Abstract: Dibenzofluorene derivatives having a formula selected from the group consisting of and salts thereof have antitumor activity. At least one of R1-R13 in formula (I) or R1-R12 in formula (II) is —R14Z. R14 is a substituted or unsubstituted amino or amido group having from 1-12 carbon atoms, and Z is a substituted or unsubstituted heterocyclic group having from 1-12 carbon atoms. The remainder of R1-R13 in formula (I) or R1-R12 in formula (II) are independently selected from the group consisting of hydrogen, hydroxyl, halogen, nitro, substituted or unsubstituted amino or amido groups having from 1-12 carbon atoms, and alkyl groups having 1-12 carbon atoms.
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: November 12, 2002
    Assignee: Board of Regents, The University of Texas System
    Inventors: Frederick F. Becker, Bimal K. Banik
  • Antitumor dibenzofluorene derivatives
    Publication number: 20020103191
    Abstract: Dibenzofluorene derivatives having a formula selected from the group consisting of 1
    Type: Application
    Filed: January 14, 2002
    Publication date: August 1, 2002
    Applicant: Board of Regents, The University of Texas System
    Inventors: Frederick F. Becker, Bimal K. Banik
  • Antitumor dibenzofluorene derivatives
    Patent number: 6362200
    Abstract: Dibenzofluorene derivatives having a formula selected from the group consisting of and salts thereof have antitumor activity. At least one of R1-R13 in formula (I) or R1-R12 in formula (II) is —R14Z. R14 is a substituted or unsubstituted amino or amido group having from 1-12 carbon atoms, and Z is a substituted or unsubstituted heterocyclic group having from 1-12 carbon atoms. The remainder of R1-R13 in formula (I) or R1-R12 in formula (II) are independently selected from the group consisting of hydrogen, hydroxyl, halogen, nitro, substituted or unsubstituted amino or amido groups having from 1-12 carbon atoms, and alkyl groups having 1-12 carbon atoms.
    Type: Grant
    Filed: August 8, 2000
    Date of Patent: March 26, 2002
    Assignee: Board of Regents, The University of Texas System
    Inventors: Frederick F. Becker, Bimal K. Banik
  • Antitumor dibenzofluorene derivatives
    Patent number: 6184224
    Abstract: Dibenzofluorene derivatives having a formula selected from the group consisting of and salts thereof have antitumor activity. At least one of R1-R13 in formula (I) or R1-R12 in formula (II) is —R14Z. R14 is a substituted or unsubstituted amino or amido group having from 1-12 carbon atoms, and Z is a substituted or unsubstituted heterocyclic group having from 1-12 carbon atoms. The remainder of R1-R13 in formula (I) or R1-R12 in formula (II) are independently selected from the group consisting of hydrogen, hydroxyl, halogen, nitro, substituted or unsubstituted amino or amido groups having from 1-12 carbon atoms, and alkyl groups having 1-12 carbon atoms.
    Type: Grant
    Filed: December 1, 1998
    Date of Patent: February 6, 2001
    Assignee: Board of Regents, The University of Texas System
    Inventors: Frederick F. Becker, Bimal K. Banik
  • Antitumor Chrysene derivatives
    Patent number: 6015811
    Abstract: Chrysene derivatives having the formula ##STR1## have been found to have antitumor activity. In the above formula, at least one of R.sub.1 -R.sub.12 is --R.sub.13 Z, where R.sub.13 is a substituted or unsubstituted amino or amido group having from 1-12 carbon atoms, and Z is a substituted or unsubstituted heterocyclic group having from 1-12 carbon atoms; and the remainder of R.sub.1 -R.sub.12 are independently selected from the group consisting of hydrogen, substituted or unsubstituted amino or amido groups having 1-12 carbon atoms, nitro, and substituted or unsubstituted hydrocarbyl groups having from 1-12 carbon atoms.
    Type: Grant
    Filed: October 27, 1998
    Date of Patent: January 18, 2000
    Assignee: Board of Regents, The University of Texas System
    Inventors: Frederick F. Becker, Bimal K. Banik